Search results
Moderna Breaks Out For The First Time In A Year After Covid Shot Wallops Sales Views
Investor's Business Daily· 1 day agoFurther, the company expects "higher vaccination uptake" in the U.S. if its updated Covid vaccine is...
Moderna’s sales from its only product, the COVID-19 vaccine, fell 91% from last year
Fortune via Yahoo Finance· 1 day agoModerna’s next focus is to continue rolling out mRNA vaccines, which teaches cells how to make the...
No More Yearly Flu Shots? Vaccine Mixed From 80,000 Proteins Could Be The Key
IFLScience· 2 days agoA new vaccine strategy could spell the end of yearly flu shots, by targeting part of the virus that...
Bird Flu: What's The Latest And How Worried Should We Be?
IFLScience· 2 days agoBird flu seems to be perennially in the news at the moment, and with more and more species...
Is Moderna Stock A Buy On Its Eye-Popping First-Quarter Sales Beat?
Investor's Business Daily· 1 day agoBut Moderna expects the lion's share of its sales to come in the second half of 2024. That lines up...
The Summer That COVID Went Away?
US News & World Report· 1 day agoThe milestone came and went with little fanfare. After more than four years with COVID-19, the Centers for Disease Control and Prevention recently...
Moderna loses less than expected as Covid vaccine sales beat estimates, cost cuts take hold
CNBC· 2 days agoModerna on Thursday posted a narrower-than-expected loss for the first quarter as the company's...
Moderna stock surges 15% after it beat earnings expectations despite plummeting COVID vaccine sales
Quartz· 2 days agoModerna stock soared on Thursday after its first-quarter earnings report sailed past Wall Street’s...
Are your kids scared of needles? Health First helps remove pain, fear of getting a shot
Florida Today via Yahoo News· 2 days agoMcGregor said. “I don’t like needles even now.” Children who develop intense anxiety around “jabs”...
GSK raises forecasts on strong vaccine, HIV drug sales
BioPharma Dive via Yahoo Finance· 3 days agoSales of the shingles vaccine Shingrix and the RSV shot Arexvy helped fuel quarterly revenue totals...